As SGLT2 inhibitors redefine standard of care, opportunities to establish efficacy with surrogate endpoints take a step forward, and molecular phenotyping of disease etiology enables reclassification of patients to clinically actionable subtypes; drug development for chronic kidney disease has never been more exciting. The 4th Chronic Kidney Disease Drug Development Summit is your only industry-led event dedicated […]

The FDA’s recent approval of Welireg has sparked reinvigorated confidence in the field of Transcription Factor-therapeutics and as an increasing number of drug candidates are entering preclinical and clinical programs, this is a vital moment for the field. For the first time, you can join leaders from BMS, Scorpion Therapeutics, Ikena Oncology, Kronos Bio and […]

SMi’s 3rd Annual AI in Drug Discovery Conference Conference: 14 – 15 March 2022 London, UK Website: http://www.ai-indrugdiscovery.com/PJwl Chaired by Darren Green, Director of Computational Chemistry, GSK Sponsored by: Optibrium Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from Discovery to Healthcare SMi Group is proud to present its 3rd Annual AI in […]

2021 marked a successful year for the protein degradation field with several candidates entering the clinic. As the European centric targeted protein degradation landscape matures and the number of pre-clinical candidates expected to enter clinical development in the next year grows ever more, the 2nd TPD Europe Summit returns, in person, to highlight key challenges […]

SMi’s 16th Annual Conference Parallel Trade 21-22 March, 2022 | Conference http://parallel-trade.com/pharmajournalistwl NAVIGATING THE CHALLENGES AND LEGAL LANDSCAPES OF PARALLEL TRADE SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from […]

The 3rd STING & TLR-Targeting Therapies Summit is coming at a timely inflection point in this field. With multiple TLR agonists moving into the clinic, STING agonists exposing new challenges, multiple approvals on the horizon, and more novel targets & combinations currently undergoing exciting pre-clinical validation than ever before, this unique and highly anticipated industry-focused […]

The inaugural GPCRs - Targeted Drug Discovery Summit has been established to tap into new drug discovery opportunities in undrugged and orphaned GPCRs by better understanding the complex signaling GPCR pathway, leveraging new structural and genetic data as well as, emerging screening tools and technologies and up and coming modalities. Discover data driven case studies […]

Celebrating 20 years of FDA approval and high efficacy profiles, kinase inhibitors have changed the face of oncology treatment. However, increasing resistance and safety issues limit the success of existing kinase inhibitor classes. The inaugural Next Generation Kinase Inhibitors Summit is the only industry-focused meeting dedicated to applying novel kinase biology to drug development and […]

In the context of intense scrutiny over the safety and durability of blood disease-targeted gene therapies and a flurry of excitement around novel gene editing technologies, the 3rd Gene Therapy for Blood Disorders Summit will unite the leading large pharma and innovative biotechs to share essential learnings from across this rapidly evolving field, enabling you […]

12th Annual World ADC London 29th March - 1st April 2022 London The ADC field is going from strength to strength, further catalysed in 2021 by the approvals of Zynlonta and Tivdak respectively, bringing the total number of commercially available ADCs to 11. Returning in-person in from 29th March – 1st April, be part of the 12th Annual World ADC […]

2021 was a game-changing year for the NK cell community. Positive clinical results have forced the field to wake up to the potential of these pioneering approaches. Supporting the field since its’ infancy, the Innate Killer Summit returns for its 7th year as the leading, industry-defining forum dedicated to advancing the field to achieve clinical success. Spanning the current […]